ATAI Life Sciences NV (NAS:ATAI)
$ 1.35 0.17 (14.41%) Market Cap: 226.53 Mil Enterprise Value: 129.29 Mil PE Ratio: 0 PB Ratio: 1.18 GF Score: 44/100

ATAI Life Sciences NV Announces Strategic Investment in Beckley Psytech Ltd Call Transcript

Jan 04, 2024 / 01:00PM GMT
Release Date Price: $1.72 (+14.67%)
Operator

Hello ladies and gentlemen, thank you for standing by, and welcome to atai Life Sciences conference call. (Operator Instructions) As a reminder, today's call is being recorded.

Earlier this morning, atai Life Sciences issued a press release providing the details of the strategic investment in Beckley Psytech. The press release is available in the Investor Relations section of the company's website. As a reminder, during today's call, atai Life Sciences will be making certain forward-looking statements within the meanings of the Private Securities Litigation Reform Act of 1995, including our business plans and objectives, and timing and success of our clinical trials, regulatory applications, and commercial launches.

Such forward-looking statements are not guarantees of future performance and therefore, you should not put undue reliance upon them. These statements are subject to numerous risks and uncertainties that could cause actual results to differ materially from what we expect. atai refers you to the company's SEC filings for discussion of risk factors that could cause our actual

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot